Company / Share Buybacks
ANI Pharmaceuticals, Inc. Share Buybacks History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
$12.2M
FY2025
5-year range
$890.0K / $12.2M
FY2021-FY2025
Trend
+11.4%
vs FY2024
Sector context
#35 of 48
Health Care
What the data says
At $12M, ANI Pharmaceuticals, Inc.'s share buybacks ranks #35 of 48 in the Health Care sector. Share Buybacks has increased for 4 consecutive years, from $890,000 in FY2021 to $12M in FY2025.
Based on SEC 10-K filings.
$12M in FY2025 with a 5-year CAGR of +51.6%.
Improved from $5M to $12M over the past 2 years.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- +84.0%
- 5-Year CAGR
- +51.6%
- 10-Year CAGR
- -
Sector benchmark
#35 of 48 in Health CareTop 73% of 48This company $12.2M Sector average $611.9M
▼
-98.0% below sector average
Key checks
Key Insights
- ANI Pharmaceuticals, Inc.'s share buybacks has grown for 4 consecutive years.
- 5-year CAGR of +51.6%, indicating consistent growth.
- In FY2025, share buybacks increased 11.4% year-over-year.
- Ranks #35 out of 48 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.2M | +11.4% |
| FY2024 | $11.0M | +119.8% |
| FY2023 | $5.0M | +154.6% |
| FY2022 | $2.0M | +120.1% |
| FY2021 | $890.0K | -41.6% |
| FY2020 | $1.5M | +47.7% |
| FY2019 | $1.0M | - |
| FY2018 | $0 | - |
| FY2017 | $0 | -100.0% |
| FY2016 | $2.5M | +477.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026